Dr. Warren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- I am a board certified dermatopathologist. My current research interests focus on the application of molecular technologies including spatial transcriptomics and NGS to diagnosis and treatment of cutaneous disease, particularly melanoma, histiocytic neoplasia and lymphoma. I maintain clinical effort in Dermatopathology and teaching.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Dermatopathology, 2000 - 2001
Medical College of Wisconsin Affiliated HospitalsResidency, Pathology-Anatomic and Clinical, 1995 - 1998
University of London Faculty of MedicineClass of 1993
Certifications & Licensure
MI State Medical License 2024 - 2027
IN State Medical License 2008 - 2025
FL State Medical License 2005 - 2011
WI State Medical License 1996 - 2011
NC State Medical License 2001 - 2010
VA State Medical License 2007 - 2010
CO State Medical License 2007 - 2009- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- Histopathologic, genomic, transcriptomic, and functional characteristics of eight melanocytic tumors with BRAF fusions showing stronger MAPK pathway activation compare...Aofei Li, Simon J Warren, Brandon A Umphress, Ahmed K Alomari
Journal of Cutaneous Pathology. 2024-11-01 - 3 citationsMAP2K1-mutated melanocytic tumors have reproducible histopathologic features and share similarities with melanocytic tumors with BRAF V600E mutations.Ahmed K Alomari, Paul W Harms, Aleodor A Andea, Simon J Warren
Journal of Cutaneous Pathology. 2023-12-01 - 2 citationsUtility of sequencing for ATP6AP1 and ATP6AP2 to distinguish between atypical granular cell tumor with junctional component and melanoma.Simon J Warren, Ahmed K Alomari
Journal of Cutaneous Pathology. 2023-11-01
Authored Content
- The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in BrazilJuly 2000
- The role of subclass switching in the pathogenesis of endemic pemphigus foliaceusJanuary 2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
